ETC
INDV icon

Exchange Traded Concepts’s Indivior Pharmaceuticals INDV Stock Holding History

Exchange Traded Concepts’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
73,712
+1,579
+2% +$57.3K 0.01% 592
2026
Q1 		$2.2M Buy
+72,133
New +$2.38M 0.02% 580

Other funds holding INDV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Exchange Traded Concepts's INDV Position: Q2 2026 in Review

Exchange Traded Concepts increased its Indivior Pharmaceuticals (INDV) stake by 2.2% in Q2 2026, buying an estimated $57.3K and bringing the position to 73,712 shares worth $3.02M. The position accounts for 0.01% of the portfolio, ranked #592.

Exchange Traded Concepts first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 49 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Exchange Traded Concepts held 73,712 shares of Indivior Pharmaceuticals worth $3.02M as of Q2 2026.
  • Exchange Traded Concepts bought 1,579 Indivior Pharmaceuticals shares in Q2 2026, an estimated $57.3K.
  • Indivior Pharmaceuticals made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #592 holding.
  • Exchange Traded Concepts first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 49 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.